Intellicheck (NASDAQ: IDN) upgraded by Zacks Investment Research to “Conserve”

Intellicheck (NASDAQ: IDN) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note released Wednesday, reports.

According to Zacks, “Intellicheck Mobilisa is a leading technology company that develops and markets wireless technologies and identity systems for a variety of applications including: mobile and portable wireless devices for government, military and commercial markets. Products include the Defense Identification System, an advanced identification card access control product currently protecting more than 70 military and federal sites. ID-Check is a technology that instantly reads, analyzes, and verifies data encoded in magnetic stripes and barcodes on government-issued IDs from approximately 60 U.S. and Canadian jurisdictions to determine if the content and format are valid. The company’s products are used in the fight against government and commercial fraud, focusing on age verification, secure access control and software tools, driver’s license readers and validation markets. ‘identity. Intelli-Check Mobilisa sells its products through its direct sales force and marketing partners. The company is headquartered in Port Townsend, W ashington. “

A number of other equity research analysts have also recently published reports on the stock. TheStreet downgraded Intellicheck’s shares from a “c-” rating to a “d +” rating in a report released on Friday, November 12. Craig Hallum downgraded Intellicheck’s stock from a “buy” rating to a “keep” rating and set a target price of $ 8.50 for the stock. in a report on Thursday, November 11. Two investment analysts rated the stock with a conservation rating and three issued a buy rating for the stock. According to data from, the stock currently has a consensus rating of “Buy” and a consensus target price of $ 12.90.

(A d)

Whether you are looking to learn the basics of futures or are a seasoned veterinarian looking to hone your trading skills, our technical analysis guide has everything you need to be successful in today’s futures markets. hui!

Intellicheck stock opened at $ 4.97 on Wednesday. Intellicheck has a 12 month low of $ 4.40 and a 12 month high of $ 15.45. The company’s fifty-day moving average is $ 5.73 and its 200-day moving average is $ 7.54. The company has a market cap of $ 93.10 million, a PE ratio of -62.12 and a beta of 1.75.

Intellicheck (NASDAQ: IDN) last released its results on Wednesday, November 10. The company reported ($ 0.05) earnings per share (EPS) for the quarter, reaching the Thomson Reuters consensus estimate of ($ 0.05). The company posted revenue of $ 4.83 million in the quarter, compared to $ 4.19 million according to analysts’ estimates. Intellicheck had a negative net margin of 9.57% and a negative return on equity of 9.60%. On average, analysts expect Intellicheck to post -0.2 earnings per share for the current fiscal year.

In other Intellicheck news, Chairman Garrett Gafke bought 18,000 shares in a trade that took place on Friday, December 10. The shares were purchased at an average cost of $ 5.61 per share, for a total value of $ 100,980.00. The purchase was disclosed in a legal file with the SEC, which is available at this link. In the past ninety days, insiders have purchased 26,700 shares of the company valued at $ 144,391. Insiders own 6.04% of the shares of the company.

Several institutional investors and hedge funds have recently changed their holdings to IDNs. Wasatch Advisors Inc. purchased a new position in Intellicheck shares during the third quarter valued at approximately $ 8,321,000. Penbrook Management LLC increased its position in Intellicheck shares by 107.8% during the 3rd quarter. Penbrook Management LLC now owns 259,430 shares of the company valued at $ 2,125,000 after purchasing an additional 134,600 shares in the last quarter. AWM Investment Company Inc. increased its position in Intellicheck shares by 100.0% during the 2nd quarter. AWM Investment Company Inc. now owns 250,010 shares of the company valued at $ 2,093,000 after purchasing an additional 125,000 shares during the last quarter. Millennium Management LLC increased its position in Intellicheck by 218.1% in the 2nd quarter. Millennium Management LLC now owns 142,190 shares of the company valued at $ 1,190,000 after acquiring an additional 97,489 shares during the last quarter. Finally, Ergoteles LLC purchased a new position in Intellicheck in the second quarter valued at $ 662,000. 44.77% of the shares are currently held by institutional investors and hedge funds.

About Intellicheck

Intellicheck, Inc is engaged in the development, integration and commercialization of threat and identity authentication solutions. It offers professional, retail, age, defense, guest and port identification services. The company was founded in 1994 and is headquartered in Melville, NY.

See also: Equal Weight Rating

Get a Free Copy of Zacks’ Research Report on Intellicheck (IDN)

For more information on Zacks Investment Research’s research offerings, visit

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]

Should you invest $ 1,000 in Intellicheck now?

Before you consider Intellicheck, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold of… and Intellicheck was not on the list.

Although Intellicheck currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.

See the 5 actions here

About Marion Browning

Check Also

San Diego County COVID Vaccination Clinics Now Accepting More IDs

San Diego County has changed its public COVID-19 vaccination policy to indicate that its vaccination …